2017
DOI: 10.1111/odi.12747
|View full text |Cite
|
Sign up to set email alerts
|

Use of antidepressants in dentistry: A systematic review

Abstract: Antidepressants may be effective in dentistry for acute and chronic pain, but there is a large amount of methodological heterogeneity among the evaluated studies. In summary, there is rationality for the indication of this class of medicine in dentistry in specific clinical situations.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
1
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 61 publications
0
1
0
Order By: Relevance
“…They include antidepressants, opioids, sedative‐anxiolytics, and antipsychotics, which are used in the treatment of an array of mental diseases and conditions (Becker, 2008; Thronson & Pagalilauan, 2014). Considering dental medicine, the recommendation of psychotropic drugs is slightly more restricted; thus, they can be considered a therapeutic option for managing chronic orofacial pain, dental fear or anxiety, bruxism, and temporomandibular disorders (Bendtsen et al, 2020; de Souza et al, 2018; Lino et al, 2018). Notably, some pharmacoepidemiologic research has shown an upward trend in the prescription of these drugs by dental practitioners (Gupta et al, 2018; Hollingworth et al, 2017; Park et al, 2020; Teoh et al, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…They include antidepressants, opioids, sedative‐anxiolytics, and antipsychotics, which are used in the treatment of an array of mental diseases and conditions (Becker, 2008; Thronson & Pagalilauan, 2014). Considering dental medicine, the recommendation of psychotropic drugs is slightly more restricted; thus, they can be considered a therapeutic option for managing chronic orofacial pain, dental fear or anxiety, bruxism, and temporomandibular disorders (Bendtsen et al, 2020; de Souza et al, 2018; Lino et al, 2018). Notably, some pharmacoepidemiologic research has shown an upward trend in the prescription of these drugs by dental practitioners (Gupta et al, 2018; Hollingworth et al, 2017; Park et al, 2020; Teoh et al, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…São diversos os fatores externos e condições sistémicas que têm vindo a ser associados ao bruxismo. Como resultado, a utilização de fármacos como antidepressivos e ansiolíticos, assim como o consumo de álcool, nicotina e cafeína tem vindo a aumentar consideravelmente (SILVA, 2018). Em indivíduos saudáveis, o bruxismo não deve ser considerado como um distúrbio, mas sim como um comportamento que pode ser um fator de risco (e/ou protetor) para certas consequências clínicas (LOBBEZOO et al, 2018).…”
Section: Introductionunclassified